Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ujj

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Orvosi Hetilap|May 9, 2001
[Molecular biology examination in chronic lymphocytic leukemia]B Telek, L Rejtó, G Mezei, et al.
Orvosi Hetilap|October 12, 2000
[Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia]L Rejtó, M Balázs, R Adány, et al.
International Journal of Hematology|October 15, 2015
Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphomaZsofia Simon, S Barna, Z Miltenyi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)S Kerpel-Fronius, V Erdélyi-Tóth, F Gyergyay, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Orvosi Hetilap|May 9, 2001
[Molecular biology examination in chronic lymphocytic leukemia]B Telek, L Rejtó, G Mezei, et al.
Orvosi Hetilap|October 12, 2000
[Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia]L Rejtó, M Balázs, R Adány, et al.
International Journal of Hematology|October 15, 2015
Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphomaZsofia Simon, S Barna, Z Miltenyi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)S Kerpel-Fronius, V Erdélyi-Tóth, F Gyergyay, et al.
Pageof 2